{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T05:26:38Z","timestamp":1764912398163,"version":"3.46.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>to extensively investigate the relationship between serum total alkaline phosphatase (ALP) and osteoporosis in a large-scale population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>people who took routine health examinations between 2019 and 2024 at a teaching hospital were included. The health examination records were reviewed, and data were extracted. The variables included anthropomorphic measurements, laboratory tests, and biochemical indices. Osteoporosis was defined by bone mineral density at the spine and hip. The relationship between ALP and osteoporosis was analyzed by using logistic regression, Receiver Operating Characteristic (ROC) analysis, and restricted cubic spline analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>total ALP in serum was significantly higher in osteoporosis than in non-osteoporosis groups(P&amp;lt;0.001). The relationship between ALP and osteoporosis was persistent in multivariate analysis after adjusting for available confounders. There was a non-linear relationship between ALP and osteoporosis; when ALP was greater than 100 IU\/L, the relationship became less pronounced. The relationships between ALP and osteoporosis were stronger in younger, female, and metabolically healthy populations with normal liver enzymes. The best cut-off value for ALP to predict osteoporosis was 72IU\/L in ROC analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>the serum total ALP in serum persistently and negatively relates to the risk of osteoporosis in a general adults population when ALPs are clinic normal. The 72IU\/Lof total serum ALP may be considered as a tentative threshold for initiating further bone health counseling in health management for adults. Cohort studies on the application of ALP in the prediction of osteoporosis or osteoporotic fracture are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1657631","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T05:13:19Z","timestamp":1764911599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The relationship between serum total alkaline phosphatase and risk of osteoporosis: a cross-sectional study"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-3014-9","article-title":"Accelerated bone loss and increased post-fracture mortality in elderly women and men","volume":"26","author":"Bliuc","year":"2015","journal-title":"Osteoporos Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e2121106","DOI":"10.1001\/jamanetworkopen.2021.21106","article-title":"Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02138-w","article-title":"Treatment of osteoporosis and osteoarthritis in the oldest old","volume":"85","author":"Fuggle","year":"2025","journal-title":"Drugs"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0408-8","article-title":"Circulating markers of bone turnover","volume":"30","author":"Vervloet","year":"2017","journal-title":"J Nephrol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1997.2221055.x","article-title":"Comparison of bone and total alkaline phosphatase activity on bone turnover during menopause and in patients with established osteoporosis","volume":"47","author":"Takahashi","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s13018-020-02073-y","article-title":"Increasing serum alkaline phosphatase is associated with bone deformity progression for patients with polyostotic fibrous dysplasia","volume":"15","author":"Wang","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07324-w","article-title":"Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005\u20132018","volume":"36","author":"Chen","year":"2024","journal-title":"Osteoporos Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12891-022-05438-y","article-title":"The correlation between serum total alkaline phosphatase and bone mineral density in young adults","volume":"23","author":"Shu","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7075815","article-title":"Association of hypertension and lipid profile with osteoporosis","volume":"2020","author":"Al-Hariri","year":"2020","journal-title":"Scientifica (Cairo)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4103\/tcmj.tcmj_113_19","article-title":"Significant association factors of bone mineral density in Taiwan adults","volume":"32","author":"Chuang","year":"2019","journal-title":"Tzu Chi Med J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5325813","article-title":"The value of serum adiponectin in osteoporotic women: does weight have an effect","volume":"2021","author":"Roomi","year":"2021","journal-title":"J Obes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e23112","DOI":"10.1002\/jcla.23112","article-title":"Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus","volume":"34","author":"Zhao","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/10790268.2021.1977905","article-title":"The use of alkaline phosphatase as a bone turnover marker after spinal cord injury: A scoping review of human and animal studies","volume":"46","author":"Ponzano","year":"2023","journal-title":"J Spinal Cord Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2174\/1871530319666190204165207","article-title":"Biomarkers of osteoporosis: an update","volume":"19","author":"Parveen","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/bf01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporosis Int"},{"key":"B16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: overview and practical use for clinicians","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-024-07324-w","article-title":"Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005-2018","volume":"36","author":"Chen","year":"2025","journal-title":"Osteoporos Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102124","article-title":"Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease","volume":"14","author":"Haarhaus","year":"2022","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-023-08666-0","article-title":"Biomarkers of liver diseases","volume":"50","author":"Tamber","year":"2023","journal-title":"Mol Biol Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/42.11.1796","article-title":"Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases","volume":"42","author":"Woitge","year":"1996","journal-title":"Clin Chem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18926\/AMO\/61205","article-title":"Clinical application of the ratio of serum bone isoform to total alkaline phosphatase in general practice","volume":"74","author":"Yokota","year":"2020","journal-title":"Acta Med Okayama"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/10815589221141830","article-title":"Serum liver enzymes and metabolic syndrome from the Rafsanjan Cohort Study","volume":"71","author":"Khalili","year":"2023","journal-title":"J Investig Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.10.015","article-title":"Serum alkaline phosphatase level is positively associated with metabolic syndrome: A nationwide population-based study","volume":"500","author":"Kim","year":"2020","journal-title":"Clin Chim Acta"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1657631\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T05:13:20Z","timestamp":1764911600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1657631\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":23,"alternative-id":["10.3389\/fendo.2025.1657631"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1657631","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"article-number":"1657631"}}